Back to the complete issue
Monday, 20 July 2020

Ibnsina considers minority share purchases through new SPV

M&A WATCH- Ibnsina Pharma is looking potential investments in unnamed pharma manufacturing companies through a newly-established special purpose vehicle (SPV), according to an EGX disclosure (pdf). The company is studying “a number” of potential investments and is closing in on signing non-binding offers for the purchase of minority stakes.

Enterprise is a daily publication of Enterprise Ventures LLC, an Egyptian limited liability company (commercial register 83594), and a subsidiary of Inktank Communications. Summaries are intended for guidance only and are provided on an as-is basis; kindly refer to the source article in its original language prior to undertaking any action. Neither Enterprise Ventures nor its staff assume any responsibility or liability for the accuracy of the information contained in this publication, whether in the form of summaries or analysis. © 2020 Enterprise Ventures LLC.